Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 6, 1994Proceedings of the National Academy of SciencesOpen Access

In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair.

View Full Paper
Ask AI
Bookmark
Share

Authors

CAChristoph AndreeDüsseldorf University HospitalWSWilliam F. SwainRoyal Hampshire County HospitalCPClive PageKing's College London

Discussion

Loading...

Member takes

Implication

In vivo experimental study demonstrates accelerated wound closure in porcine skin, indicating that targeted epidermal growth factor gene delivery enhances tissue repair.

Key Points

  • To evaluate whether in vivo transfer and local expression of a human epidermal growth factor plasmid can accelerate partial-thickness wound healing.
  • Transferred a human epidermal growth factor (hEGF) expression plasmid into porcine partial-thickness wound keratinocytes via particle-mediated DNA transfer (Accell).
  • Applied a sealed, fluid-filled external wound chamber to shield wounds, isolate exogenous DNA and expressed peptides, and sample wound fluid over a 10-day period.
  • Wounds bombarded with the hEGF plasmid demonstrated a 190-fold increase in EGF concentration, declining from 200 pg/ml to 25 pg/ml over the initial 5 days and remaining detectable across 10 days.
  • Treated wounds achieved re-epithelialization 20% (2.1 days) earlier than controls, and plasmid DNA remained detectable by polymerase chain reaction for at least 30 days.

Cite This Study

Andree et al. (1994) studied this question.

synapsesocial.com/papers/6a19beaa05af093a17f6801ahttps://doi.org/10.1073/pnas.91.25.12188
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Basic Science of Gene Therapy1993 · 1,764 citations
  2. 2Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits1991 · 370 citations
  3. 3Safety Issues Related to Retroviral-Mediated Gene Transfer in Humans1991 · 205 citations
  4. 4Safety Considerations in Somatic Gene Therapy of Human Disease with Retrovirus Vectors1990 · 151 citations
  5. 5Human growth hormone DNA sequence and mRNA structure: possible alternative splicing1981 · 463 citations